Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5)

Molecular Cancer Research

Volumn 7, Issue 4, 2009, Pages 462-475

  Carpenter, Philip M ^a,g   Dao, Anh V ^a,e   Arain, Zahida S ^a   Chang, Michelle K ^a   Nguyen, Hoa P ^a,f   Arain, Shehla ^a   Wang Rodriguez, Jessica ^b   Kwon, Soon Young ^a,c   Wilczynski, Sharon P ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Korea University   (South Korea)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e GENZYME GENETICS   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA3 INTEGRIN; BETA1 INTEGRIN; KALININ; CELL ADHESION MOLECULE; INTEGRIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CELL MOTILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BREAST TUMOR; CANCER INVASION; CELL ADHESION; CELL MOTION; CULTURE MEDIUM; ENZYME IMMUNOASSAY; EPITHELIUM CELL; FEMALE; INTRADUCTAL CARCINOMA; MAMMARY GLAND; METABOLISM; METAPLASIA; MIDDLE AGED; MOLECULAR WEIGHT; PATHOLOGY; PHYSIOLOGY; SARCOMA; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTEGRINS; MAMMARY GLANDS, HUMAN; METAPLASIA; MIDDLE AGED; MOLECULAR WEIGHT; NEOPLASM INVASIVENESS; SARCOMA;

EID: 65549119715     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0148     Document Type: Article

References (76)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70. (Pubitemid 30046295)
2. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003;3:362-374 (Pubitemid 37328856)
3. Mareel MM, De Baetselier P, Van Roy FM. Mechanisms of invasion and metastasis. CRC Press: Boca Raton; 1991. pp. 73-220.
4. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006;127:679-695
5. Wells A. Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res 2000;78:31-101.
6. McCarthy JB, Basara ML, Palm SL, Sas DF, Furcht LT. The role of cell adhesion proteins - laminin and fibronectin - in the movement of malignant and metastatic cells. Cancer Metastasis Rev 1985;4:125-152
7. Ronnov-Jessen L, Van Deurs B, Nielsen M, Petersen OW. Identification, paracrine generation and possible function of human breast carcinoma myofibroblasts in culture. In Vitro Cell Dev Biol 1992;28A:273-283
8. Kantor JD, Zetter BR. Cell motility in breast cancer. In: Dickson R, Lippman M, editors. Mammary tumor cell cycle, differentiation and metastasis. Boston: Kluwer Academic Publishers; 1996. pp. 303-323
9. Stracke ML, Aznavoorian SA, Beckner ME, Liotta LA, Schiffmann E. Cell motility, a principal requirement for metastasis. Exs 1991;59:147-162
10. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003;3:921-930 (Pubitemid 37500177)
11. Carpenter PM, Nguyen HP. Mammary epithelium-induced motility of MCF-7 cells. Anticancer Res 1998;18:1063-1068 (Pubitemid 28239641)
12. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6:392-401.
13. Goswami S, Sahai E, Wyckoff JB, et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005;65:5278-5283
14. Carpenter PM, Gatanaga T, Nguyen HP, Hiserodt JC. Lymphocyte and monocyte-induced motility of MCF-7 cells by tumor necrosis factor α. Int J Cancer 1997;71:64-70. (Pubitemid 27158411)
15. Jiang WG, Hiscox S, Hallett MB, Mansel RE, Puntis MC. Regulation of motility and invasion of cancer cells by human monocytic cells. Anticancer Res 1995;15:1303-1310
16. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001;411:375-379
17. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996;76:69-125. (Pubitemid 26048279)
18. Shekhar MP, Pauley R, Heppner G. Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res 2003;5:130-135
19. Aumailley M, Bruckner-Tuderman L, Carter WG, et al. A simplified laminin nomenclature. Matrix Biol 2005;24:326-332
20. Sonnenberg A, de Melker AA, Martinez de Velasco AM, Janssen H, Calafat J, Niessen CM. Formation of hemidesmosomes in cells of a transformed murine mammary tumor cell line and mechanisms involved in adherence of these cells to laminin and kalinin. J Cell Sci 1993;106:1083-1102 (Pubitemid 24018396)
21. Zhang K, Kramer RH. Laminin 5 deposition promotes keratinocyte motility. Exp Cell Res 1996;227:309-322 (Pubitemid 26320173)
22. Kainulainen T, Hakkinen L, Hamidi S, et al. Laminin-5 expression is independent of the injury and the microenvironment during reepithelialization of wounds. J Histochem Cytochem 1998;46:353-360
23. 1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J Cell Sci 1999;112:2615-2629
24. Hintermann E, Quaranta V. Epithelial cell motility on laminin-5: regulation by matrix assembly, proteolysis, integrins and erbB receptors. Matrix Biol 2004;23:75-85. (Pubitemid 38891522)
25. Plopper GE, Domanico SZ, Cirulli V, Kiosses WB, Quaranta V. Migration of breast epithelial cells on laminin-5: differential role of integrins in normal and transformed cell types. Breast Cancer Res Treat 1998;51:57-69. (Pubitemid 28550160)
26. O'Toole EA, Marinkovich MP, Hoeffler WK, Furthmayr H, Woodley DT. Laminin-5 inhibits human keratinocyte migration. Exp Cell Res 1997;233:330-339 (Pubitemid 27252013)
27. 4 integrin and activates RAC and NF κB to mediate anchorage-independent survival of mammary tumors. J Cell Biol 2003;163:1397-1407
28. Miyazaki K. Laminin-5 (laminin-332): unique biological activity and role in tumor growth and invasion. Cancer Sci 2006;97:91-98 (Pubitemid 43379475)
29. Aumailley M, El Khal A, Knoss N, Tunggal L. Laminin 5 processing and its integration into the ECM. Matrix Biol 2003;22:49-54. (Pubitemid 36444506)
30. Katayama M, Sekiguchi K. Laminin-5 in epithelial tumour invasion. J Mol Histol 2004;35:277-286 (Pubitemid 40585313)
31. Giannelli G, Antonaci S. Biological and clinical relevance of laminin-5 in cancer. Clin Exp Metastasis 2000;18:439-443 (Pubitemid 32844245)
32. Stampfer M, Yaswen P. Culture systems for study of human mammary epithelial cell proliferation, differentiation and transformation. Cancer Surv 1993;18:7-34. (Pubitemid 24110631)
33. Karnoub AE, Weinberg RA. Chemokine networks and breast cancer metastasis. Breast Dis 2007;26:75-85.
34. Patarroyo M, Tryggvason K, Virtanen I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol 2002;12:197-207.
35. Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB. Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest 1996;98:1509-1518 (Pubitemid 26327858)
36. Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD. MDA-MB-435 cells are derived from M14 melanoma cells - a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 2007;104:13-19 (Pubitemid 46976633)
37. 1 integrin (VLA-3). Clin Exp Metastasis 2002;19:127-134
38. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-687 (Pubitemid 35283958)
39. Carpenter PM, Wang-Rodriguez J, Chan OTM, Wilczynski SP. Laminin 5 expression in metaplastic breast carcinomas. Am J Surg Pathol 2007;32:345-353
40. Beatty JD, Atwood M, Tickman R, Reiner M. Metaplastic breast cancer: clinical significance. Am J Surg 2006;191:657-664
41. Pezzi CM, Patel-Parekh L, Cole K, Franko J, Klimberg VS, Bland K. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the national cancer data base. Ann Surg Oncol 2007;14:166-173
42. Luini A, Aguilar M, Gatti G, et al. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat 2007;101:349-353
43. Henning K, Berndt A, Katenkamp D, Kosmehl H. Loss of laminin-5 in the epithelium-stroma interface: an immunohistochemical marker of malignancy in epithelial lesions of the breast. Histopathology 1999;34:305-309 (Pubitemid 29229984)
44. Yu HM, Frank DE, Zhang J, You X, Carter WG, Knudsen BS. Basal prostate epithelial cells stimulate the migration of prostate cancer cells. Mol Carcinog 2004;41:85-97. (Pubitemid 39336758)
45. 1-mediated interaction with laminin-5 stimulates adhesion, migration and invasion of malignant glioma cells. Int J Cancer 1998;76:63-72.
46. 3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity. Neoplasia 2004;6:468-479
47. Martin KJ, Kwan CP, Nagasaki K, et al. Down-regulation of laminin-5 in breast carcinoma cells. Mol Med 1998;4:602-613
48. Hendrix MJ, Seftor EA, Kirschmann DA, Quaranta V, Seftor RE. Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann N Y Acad Sci 2003;995:151-161 (Pubitemid 36706622)
49. 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 1994;145:782-791
50. Wang W, Wyckoff JB, Frohlich VC, et al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res 2002;62:6278-6288
51. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-10874
52. 2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion. Cancer Res 2003;63:222-229
53. Korah R, Kasturi D, Lindy ME, Hameed M, Wieder R. Coordinate loss of fibroblast growth factor 2 and laminin 5 expression during neoplastic progression of mammary duct epithelium. Hum Pathol 2007;38:154-160
54. Yuen HW, Ziober AF, Gopal P, et al. Suppression of laminin-5 expression leads to increased motility, tumorigenicity, and invasion. Exp Cell Res 2005;309:198-210.
55. Faverly DRG, Burgers D, Bult P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994;11:193-198 (Pubitemid 24308079)
56. 4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer. Mod Pathol 2005;18:1165-1175
57. Miller FR, McInerney D. Epithelial component of host-tumor interactions in the orthotopic site preference of a mouse mammary tumor. Cancer Res 1988;48:3698-3701 (Pubitemid 18176843)
58. Price JE. Metastasis from human breast cancer lines. Breast Cancer Res Treat 1996;39:93-102. (Pubitemid 26136507)
59. Unimori EN, Ways N, Pitelka DR. Metastasis of murine mammary tumour lines from the mammary gland and ectopic sites. Br J Cancer 1984;49:603-614 (Pubitemid 14101683)
60. Miller FR, McEachern D, Miller BE. Growth regulation of mouse mammary tumor cells in collagen gel cultures by diffusible factors produced by normal mammary gland epithelium and stromal fibroblasts. Cancer Res 1989;49:6091-6097 (Pubitemid 19274175)
61. Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004;6:17-32.
62. Zhu G, Reynolds L, Crnogorac-Jurcevic T, et al. Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer. Oncogene 2003;22:3742-3748
63. Man YG, Sang QX. The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis. Exp Cell Res 2004;301:103-118
64. Polyak K, Hu M. Do myoepithelial cells hold the key for breast tumor progression?. J Mammary Gland Biol Neoplasia 2005;10:231-247
65. Ervin PR, Kaminski MS, Cody RL, Welch MS. Production of mammastatin, a tissue-specific growth inhibitor, by human mammary cells. Science 1989;244:1585-1587 (Pubitemid 19189738)
66. Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994;263:526-529
67. 2/M arrest and apoptosis. Exp Cell Res 1998;241:394-403.
68. Sternlicht MD, Kedeshian P, Shao Z-M, Safarians S, Barsky SH. The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res 1997;3:1949-1958. (Pubitemid 27505120)
69. Xiao G, Liu YE, Gentz R, et al. Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells. Proc Natl Acad Sci U S A 1999;96:3700-3705
70. Barsky SH, Karlin NJ. Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J Mammary Gland Biol Neoplasia 2005;10:249-260
71. Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci 2002;115:39-50. (Pubitemid 34105527)
72. Verhasselt B, Van Damme J, van Larebeke N, et al. Interleukin-1 is a motility factor for human breast carcinoma cells in vitro: additive effect with interleukin-6. Eur J Cell Biol 1992;59:449-457
73. Mann M, Pandey A. Use of mass spectrometry-derived data to annotate nucleotide and protein sequence databases. Trends Biochem Sci 2001;26:54-61. (Pubitemid 32124711)
74. Bae SN, Arand G, Azzam H, et al. Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res Treat 1993;24:241-255
75. Carter MR, Hornick JL, Lester S, Fletcher CD. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am J Surg Pathol 2006;30:300-309 (Pubitemid 43740161)
76. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-410